Zurueck zur Suche

Reporte zur Charge UI840AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NC 1

VAERS 1032719

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UI840AA

gering
Staat
NC
Alter
-
Geschlecht
F
Eingang
16.02.2021
Impfdatum
08.10.2017
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Eyelid exfoliation Lymphadenopathy Ocular hyperaemia Pharyngeal swelling Swelling face

Symptomtext

swelling in throat glands; red eyes; face swelling; scaling on her eye lashes; Initial information was received on 27-Jan-2021 regarding an unsolicited valid non-serious case from a consumer or consumer or other non-professional (patient). This case involves a 82 year old female patient who experienced red eyes (ocular hyperaemia), swelling in throat glands (pharyngeal swelling), face swelling (swelling face) and scaling on her eye lashes (eyelid exfoliation), after she received INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT]. In 2017, patient was taking the FLUZONE QUADRIVALENT as previous vaccination with no side effects. Medical history, medical treatment, family history and concomitant medication were not provided. On 08-Oct-2017, the patient received a first dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [lot UI840AA, 04-Jun-2018] via an unknown route at an unknown administration site for prophylactic vaccination. On an unknown date, the patient developed a non-serious red eyes (ocular hyperaemia), swelling in throat glands (pharyngeal swelling), face swelling (swelling face) and scaling on her eye lashes (eyelid exfoliation), (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE. Details of laboratory data not reported. It was reported at the time of reporting that, patient looked Asia and she is Irish. It was also reported that, patient was not wanting to take the COVID vaccine but wanted to know if she would have the same side effects as the FLUZONE HIGH-DOSE and her physicians suggested her, not take the COVID vaccine due to FLUZONE HIGH-DOSE side effects. It was not reported if the patient received any corrective treatment. At the time of reporting, event outcome was reported as unknown for all the reported events. At the time of reporting, the result of assessment reported as not reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Eyelid exfoliation
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1025016

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) · Charge UI840AA

gering
Staat
-
Alter
-
Geschlecht
M
Eingang
12.02.2021
Impfdatum
08.10.2017
Beginn
10.10.2017
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Allergy test Lymphadenopathy Ocular hyperaemia Periorbital swelling Swelling face

Symptomtext

Whites of eyes was completely red; swollen under eyes; face swelling; swollen glands in neck; Initial information regarding an unsolicited valid non-serious case was received from a consumer/non-health care professional via agecy (Reference number- 00448535) and transmitted to Sanofi on 27-Jan-2021. This case involves a male patient (age unspecified) whose whites of eyes were completely red (ocular hyperaemia), swollen under eyes (periorbital swelling), face swelling (swelling face) and swollen glands in neck (lymphadenopathy)while he received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE]. Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided. On 08-Oct-2017 (on Sunday), the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot UI840AA, expiry: 06-Apr-2018) via unknown route in unknown administration site for prophylactic vaccination. On 09-Oct-2017 (on Monday), she had fish On 10-Oct-2017 (Tuesday afternoon), the patient's whites of eyes were completely red (ocular hyperaemia), swollen under eyes (periorbital swelling), face swelling (swelling face) and swollen glands in neck (lymphadenopathy) 2 days following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. These non-serious reactions were severe. The consumer was trying to get ingredients from the FLUZONE High Dose vaccine she got on 08-Oct-2017, so that she could determine if she is able to get the coronavirus disease (COVID-19) vaccine and why she had the reaction to the high dose (HD) flu vaccine. She had a severe reaction to Sanofi's High dose Flu vaccine. In Oct-2017 she had Sanofi (HD) flu shot for the 1st time and she had a severe reaction. The patient stated that she never had a reaction to the regular dose of Flu vaccine before and is not sure why she reacted to the high dose flu vaccine. Patient had a picture of how her face looked with the reaction. She did not recall having a fever. She went to Urgent Care. Relevant laboratory test results included: Allergy test showed that nothing else was involved It was not reported if the patient received a corrective treatment. At the time of report, the outcome of event was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Allergy test
Hospital-Tage
-
Labordaten
Test Name: allergy test; Result Unstructured Data: nothing else was involved
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-